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Background
Vitiligo is a skin disorder that affects 1% to 2% of the
world population, independently of ethnicity. It presents
with white plaques and skin discoloration. The presence
of antibodies against melanocytes confirms the autoim-
mune phenomena in this disease. Regarding cellular
imune response in active vitiligo, it seems to be an
imbalance between T cell CD8+ and CD4+, and, more-
over, an altered expression of Natural Killer (NK) in
periphery, although very few data are available. We eval-
uated the cellular immune effect (T cell expression) in
peripheral blood in vitiligo patients who received anti-
genic stimulus (autologous graft), in comparison with
patients with inactive Vitiligo who received autologous
graft in comparison with patients with active Vitiligo
without grafting.
Methods
Antigenic stimulus was done with autologous skin graft
(Punch 3mm): substitution of vitiligo area with normal
skin in group A (inactive vitiligo patients), and group B
(active vitiligo patients). Group C: healthy individuals.
Quantitative numbers of T lymphocytes subpopulations
(CD3, CD4, CD8) and NK cells (CD16, CD56, CD94,
CD158a) were determined by Flow cytometry. (CD94+
refers as an inhibitor receptor expressed in NK cells,
CD158+ refers as an apoptosis receptor in NK cells).
Results
Three groups were evaluated: A) Inactive vitiligo
patients engrafted (n=10); B) active vitiligo patients
without engraftment (n=10) and C) healthy individuals
(n=10). The evaluation was performed on days 0,+8,+30,
+60 after skin engraftment. There was no difference of
CD3+CD4+ among all groups. CD3+CD8+ was lower in
patients with active vitiligo (p=0.003), CD94+ was lower
in patients with inactive vitiligo (p=0.01), both compar-
ing to healthy individuals. CD158+ was higher in
patients with active vitiligo, although there was no sta-
tistically significance.
Conclusions
Data suggests that cytotoxic activity of NK cells may be
down regulated in patients with active vitiligo.
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